Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Polycystic Ovary SyndromeNon-Alcoholic Fatty Liver Disease

Interventions

DRUG

Canagliflozin 100mg Tab

Canagliflozin 100mg once daily combined Metformin 1000mg twice daily

DRUG

Metformin Hydrochloride

Metformin 1000mg twice daily

All Listed Sponsors

lead

Ping Li,MD

OTHER

NCT06256289 - Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter